COURTNEY KIRKLAND: Open Payments
NPI 1083278311 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,190 in 129 payments from 16 companies in 2025. Trend: 2023 $2,146 · 2024 $2,090 · 2025 $2,190
Food & beverage: $2,190
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $530 |
| Amgen Inc. | 21 | $337 |
| E.R. Squibb & Sons, L.L.C. | 17 | $262 |
| UCB, Inc. | 8 | $190 |
| Organon LLC | 9 | $175 |
| Novartis Pharmaceuticals Corporation | 17 | $170 |
| Janssen Biotech, Inc. | 11 | $147 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| GENZYME CORPORATION | 2 | $66 |
| Genentech USA, Inc. | 2 | $65 |
Products named: RINVOQ, ORENCIA, SKYRIZI, Bimzelx, HADLIMA, COSENTYX, KRYSTEXXA, TREMFYA.
Industry payments across TX — which companies pay providers there.
